SEATTLE, Feb. 27, 2012 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), a vaccine technologies company specializing in the development of innovative immunotherapeutics and vaccines in the areas of oncology and infectious disease, is pleased to announce that Dr. Glynn Wilson, Chief Executive Officer, will be presenting at the 10th Annual BioPartnering North America (BPN) in Vancouver, BC, Canada, February 26-28, 2012.
